GW Pharmaceuticals Company

CNS and neurodegenerative diseases, cannabinoid-based treatments.
Technology: AgeTech Companies
Industry: Healthcare
Headquarters: United Kingdom
Founded Date: 1998
Employees Number: 501-1000
Funding Status: M&A
Investors Number: 1
Total Funding: $568.1M
Estimated Revenue: $50M to $100M
Last Funding Type: Post-IPO Equity

Visit Website
info@gwpharm.com
Register and Claim Ownership